Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
September 8, 2011
[Successful completion of left total hip arthroplasty by inhibitor neutralization therapy in a hemophilia B patient with high responding inhibitor]
Yoshihiko Ogawa, Yasuharu Nishida, Takayuki Kyo, et al.
Internal Medicine (Tokyo, Japan)
|
December 16, 2014
Rapid multiorgan failure due to large B-cell lymphoma arising in human herpesvirus-8-associated multicentric Castleman's disease in a patient with human immunodeficiency virus infection
Yoshihiko Ogawa, Dai Watanabe, Kazuyuki Hirota, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
January 30, 2017
Cross-sectional and longitudinal investigation of human herpesvirus 8 seroprevalence in HIV-1-infected individuals in Osaka, Japan
Dai Watanabe, Yudai Yamamoto, Sachiko Suzuki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 19, 2025
Month 12 outcomes of switching to long-acting cabotegravir + rilpivirine with an oral lead-in versus continuing bictegravir/emtricitabine/tenofovir alafenamide in the Phase 3b randomized SOLAR study
Eisuke Adachi, Yoshiyuki Yokomaku, Dai Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 5, 2011
Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation
Munehiro Yoshino, Hiroki Yagura, Hiroyuki Kushida, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
February 22, 2012
Increase in serum mitochondrial creatine kinase levels induced by tenofovir administration
Dai Watanabe, Munehiro Yoshino, Hiroki Yagura, et al.
Journal of Medical Virology
|
May 25, 2013
Evaluation of VZV-specific cell-mediated immunity in adults infected with HIV-1 by using a simple IFN-γ release assay
Dai Watanabe, Naruhito Otani, Sachiko Suzuki, et al.
Neurologia Medico-Chirurgica
|
February 18, 2026
Brain Lesions Associated with Human Immunodeficiency Virus Infection in the Antiretroviral Therapy Era: A Single-center Experience in Japan
Yosuke Fujimi, Katsunori Asai, Dai Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
May 18, 2025
Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial
Eisuke Adachi, Yoshiyuki Yokomaku, Dai Watanabe, et al.
BMC Infectious Diseases
|
September 17, 2017
Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1
Hiroki Yagura, Dai Watanabe, Hiroyuki Kushida, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
September 8, 2011
[Successful completion of left total hip arthroplasty by inhibitor neutralization therapy in a hemophilia B patient with high responding inhibitor]
Yoshihiko Ogawa, Yasuharu Nishida, Takayuki Kyo, et al.
Internal Medicine (Tokyo, Japan)
|
December 16, 2014
Rapid multiorgan failure due to large B-cell lymphoma arising in human herpesvirus-8-associated multicentric Castleman's disease in a patient with human immunodeficiency virus infection
Yoshihiko Ogawa, Dai Watanabe, Kazuyuki Hirota, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
January 30, 2017
Cross-sectional and longitudinal investigation of human herpesvirus 8 seroprevalence in HIV-1-infected individuals in Osaka, Japan
Dai Watanabe, Yudai Yamamoto, Sachiko Suzuki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 19, 2025
Month 12 outcomes of switching to long-acting cabotegravir + rilpivirine with an oral lead-in versus continuing bictegravir/emtricitabine/tenofovir alafenamide in the Phase 3b randomized SOLAR study
Eisuke Adachi, Yoshiyuki Yokomaku, Dai Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
October 5, 2011
Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation
Munehiro Yoshino, Hiroki Yagura, Hiroyuki Kushida, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
February 22, 2012
Increase in serum mitochondrial creatine kinase levels induced by tenofovir administration
Dai Watanabe, Munehiro Yoshino, Hiroki Yagura, et al.
Journal of Medical Virology
|
May 25, 2013
Evaluation of VZV-specific cell-mediated immunity in adults infected with HIV-1 by using a simple IFN-γ release assay
Dai Watanabe, Naruhito Otani, Sachiko Suzuki, et al.
Neurologia Medico-Chirurgica
|
February 18, 2026
Brain Lesions Associated with Human Immunodeficiency Virus Infection in the Antiretroviral Therapy Era: A Single-center Experience in Japan
Yosuke Fujimi, Katsunori Asai, Dai Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
May 18, 2025
Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial
Eisuke Adachi, Yoshiyuki Yokomaku, Dai Watanabe, et al.
BMC Infectious Diseases
|
September 17, 2017
Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1
Hiroki Yagura, Dai Watanabe, Hiroyuki Kushida, et al.
Page
of 12